Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Pepscan Therapeutics, a world leader in protein mimicry technologies for raising anti-GPCR antibodies, today announced a multi-target research...
Phylogica Ltd (ASX: PYC, XETRA: PH7), a leading Australian peptide drug discovery company, and Pepscan Therapeutics, a Dutch biopharmaceutical firm...
Pepscan Therapeutics, the Dutch biotechnology firm focusing on protein mimicry technology, today announces that it has signed a Research and License...
Pepscan Therapeutics, the Netherlands-based biotechnology firm focusing on protein mimicry technology for the generation of novel therapeutics, today ...
Pepscan Therapeutics (Pepscan), the Netherlands based biotechnology firm focusing on protein mimicry technology for the generation of novel...
Prof. Dr. Rob Meloen, de oprichter van het biotechbedrijf Pepscan, heeft op 1 september met een wetenschappelijk symposium afscheid genomen van...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.